Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Verano Holdings price target lowered to C$23 from C$24.50 at Canaccord » 13:13
05/26/22
05/26
13:13
05/26/22
13:13
VRNOF

Verano Holdings

$7.55 /

+0.37 (+5.15%)

Canaccord analyst Matt…

Canaccord analyst Matt Bottomley lowered the firm's price target on Verano Holdings to C$23 from C$24.50 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

04/28/22 Canaccord
Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord
02/11/22 Alliance Global Partners
Verano Holdings initiated with a Buy at Alliance Global Partners
02/09/22 Needham
Verano Holdings initiated with a Buy at Needham
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

Hot Stocks
Verano Holdings announces opening of Zen Leaf Westover » 07:21
05/26/22
05/26
07:21
05/26/22
07:21
VRNOF

Verano Holdings

$7.55 /

+0.37 (+5.15%)

Verano Holdings announced…

Verano Holdings announced the opening of Zen Leaf Westover, the Company's second in West Virginia dispensary and 99th location nationwide, on Friday, May 27. Zen Leaf Westover, located at 871 Fairmont Road, is open Wednesday through Saturday from 11:00 a.m. to 7:00 p.m. and 10:00 a.m. to 4:00 p.m. on Sunday, local time. Zen Leaf Westover is located in Monongalia County, the third largest county in West Virginia, with a population of over 106,0002. The dispensary is conveniently located just over one mile from the Morgantown Mall and two miles from West Virginia University, which has a population of nearly 26,000 students. Across West Virginia, Verano has permits issued by West Virginia's Office of Medical Cannabis to operate a cultivation and processing facility, along with seven total medical cannabis dispensaries that are projected to continue to open throughout 2022, subject to customary approvals.

ShowHide Related Items >><<
VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

04/28/22 Canaccord
Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord
02/11/22 Alliance Global Partners
Verano Holdings initiated with a Buy at Alliance Global Partners
02/09/22 Needham
Verano Holdings initiated with a Buy at Needham
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

Wednesday
Earnings
Verano Holdings reports Q1 revenue $202M, consensus $299.39M » 07:08
05/25/22
05/25
07:08
05/25/22
07:08
VRNOF

Verano Holdings

$7.18 /

-0.32 (-4.27%)

Q1 2022 gross profit was…

Q1 2022 gross profit was $100M or 49% of revenue, compared to $54M in the first quarter 2021; excluding an M&A inventory step up and depreciation and amortization, gross margin was 61%, up 1% from Q4 2021 on a comparable basis. Net loss in the first quarter 2022 was $7M, compared to a loss of $2 million in the first quarter 2021. "I am proud of the financial and operational performance we achieved this quarter, including sustaining our signature industry-leading margins, despite facing substantial headwinds that have affected our industry and the broader economy," said George Archos, Verano Founder and Chief Executive Officer. "We remain focused on execution, evidenced by our continued retail footprint expansion, where we added seven locations in the first quarter, including our first Zen Leaf dispensary in West Virginia. Further, the April launch of adult-use sales in New Jersey generated significant and immediate growth in the state, which is representative of similar opportunities we are poised to capitalize on in future transitioning markets in our portfolio. This summer, we are excited to add Zen Leaf Neptune as an additional adult-use dispensary in a prime Jersey Shore location, and throughout the course of 2022, we will continue to invest back in our business through a number of cultivation construction and expansion projects. Overall, we are pleased by our progress in strategically positioning Verano to capitalize on anticipated growth in the second half of the year and beyond."

ShowHide Related Items >><<
VRNOF Verano Holdings
$7.18 /

-0.32 (-4.27%)

VRNOF Verano Holdings
$7.18 /

-0.32 (-4.27%)

04/28/22 Canaccord
Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord
02/11/22 Alliance Global Partners
Verano Holdings initiated with a Buy at Alliance Global Partners
02/09/22 Needham
Verano Holdings initiated with a Buy at Needham
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
VRNOF Verano Holdings
$7.18 /

-0.32 (-4.27%)

VRNOF Verano Holdings
$7.18 /

-0.32 (-4.27%)

Monday
Hot Stocks
Verano reports dismissal of all claims in Nielsen arbitration » 07:09
05/23/22
05/23
07:09
05/23/22
07:09
VRNOF

Verano Holdings

$7.52 /

+0.47 (+6.67%)

The company said,…

The company said, "Verano Holdings notified the U.S. District Court for the District of Colorado of its complete victory in arbitration regarding various frivolous RICO claims brought by Nicholas Nielsen. The arbitrator dismissed all of Nielsen's claims with prejudice and awarded Verano nearly $100,000 in attorney's fees in the arbitration, further underscoring the groundless nature of the lawsuit. In his claims, originally brought in Federal Court but ultimately adjudicated on the merits in arbitration, Nielsen failed to disclose that he had pled guilty to a four-count felony indictment in the State of Arkansas for the blatantly illegal marijuana cultivation and production operation he ran out of his home. Nielsen's claims were a meritless effort to shift blame to Verano and more than fifty other defendants for his conviction, which was based on illegal activity in which he engaged on his own volition and without the knowledge or involvement of Verano or others. With operations in 13 states, all with highly regulated state-legalized cannabis programs, Verano is a leading, vertically integrated multi-state cannabis operator in the United States. This complete victory for Verano validates its vigorous efforts to defend itself from these false, baseless and defamatory allegations that struck at one of Verano's core foundational principles - strict compliance with applicable law."

ShowHide Related Items >><<
VRNOF Verano Holdings
$7.52 /

+0.47 (+6.67%)

VRNOF Verano Holdings
$7.52 /

+0.47 (+6.67%)

04/28/22 Canaccord
Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord
02/11/22 Alliance Global Partners
Verano Holdings initiated with a Buy at Alliance Global Partners
02/09/22 Needham
Verano Holdings initiated with a Buy at Needham
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
VRNOF Verano Holdings
$7.52 /

+0.47 (+6.67%)

VRNOF Verano Holdings
$7.52 /

+0.47 (+6.67%)

Over a week ago
Hot Stocks
Verano Holdings announces opening of MUV Ocala » 07:33
05/19/22
05/19
07:33
05/19/22
07:33
VRNOF

Verano Holdings

$7.00 /

-0.17 (-2.37%)

Verano Holdings announced…

Verano Holdings announced the opening of MUV Ocala on Friday, May 20, the Company's 47th Florida dispensary and 98th nationwide. MUV Ocala, located at 3701 SW College Road, is open Monday through Saturday from 9:00 a.m. to 7:00 p.m. and Sunday from 11:00 a.m. to 5:00 p.m., local time. MUV Ocala is located in Marion County, a rapidly growing area that experienced a population increase of 13.5% from 2010 to 2021. Ocala was also recently named the sixth fastest-growing city in the United States.

ShowHide Related Items >><<
VRNOF Verano Holdings
$7.00 /

-0.17 (-2.37%)

VRNOF Verano Holdings
$7.00 /

-0.17 (-2.37%)

04/28/22 Canaccord
Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord
02/11/22 Alliance Global Partners
Verano Holdings initiated with a Buy at Alliance Global Partners
02/09/22 Needham
Verano Holdings initiated with a Buy at Needham
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
VRNOF Verano Holdings
$7.00 /

-0.17 (-2.37%)

VRNOF Verano Holdings
$7.00 /

-0.17 (-2.37%)

Hot Stocks
Marimed awarded dispensary license in Ohio » 07:37
05/18/22
05/18
07:37
05/18/22
07:37
MRMD

Marimed

/

+

MariMed announced it had…

MariMed announced it had been awarded a provisional dispensary license, PDL, by the Ohio Board of Pharmacy. MariMed won this license in the Ohio lottery process. The license allows the Company to develop a medical dispensary in Tiffin, Ohio, located south of Toledo and home to the University of Bucharest and Tiffin University. Under the Ohio regulations, MariMed must complete the buildout and pass final inspection by February of 2023. "We are delighted to enter the medical cannabis program in Ohio," said Bob Fireman, Chief Executive Officer of MariMed. "We intend to seek additional opportunities to expand our cannabis operations in Ohio including the distribution of our award-winning branded products."

ShowHide Related Items >><<
MRMD Marimed
/

+

MRMD Marimed
/

+

09/15/21 Colliers
Marimed initiated with a Buy at Colliers
On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:00
05/16/22
05/16
10:00
05/16/22
10:00
NFLX

Netflix

$191.97 /

+4.26 (+2.27%)

, BABA

Alibaba

$87.73 /

-0.185 (-0.21%)

, PDD

Pinduoduo

$38.32 /

+0.62 (+1.64%)

, TCEHY

Tencent

$45.94 /

+1.881 (+4.27%)

, JD

JD.com

$52.10 /

+0.55 (+1.07%)

, BIDU

Baidu

$117.00 /

+0.11 (+0.09%)

, BILI

Bilibili

$20.93 /

+0.35 (+1.70%)

, NTES

NetEase

$94.12 /

+1.64 (+1.77%)

, CI

Cigna

$264.05 /

+4.84 (+1.87%)

, TTD

Trade Desk

$52.86 /

+0.925 (+1.78%)

, TWLO

Twilio

$106.55 /

-4.24 (-3.83%)

, DIS

Disney

$106.80 /

-0.56 (-0.52%)

, RNG

RingCentral

$67.23 /

-2.03 (-2.93%)

, BAND

Bandwidth

$20.15 /

-0.94 (-4.46%)

, SFT

Shift Technologies

$1.17 /

-0.025 (-2.09%)

, NLSN

Nielsen

$24.97 /

-0.17 (-0.68%)

, MPC

Marathon Petroleum

$97.02 /

+1.04 (+1.08%)

, INM

InMed Pharmaceuticals

/

+

, WOOF

Petco

$18.08 /

-0.565 (-3.03%)

, RH

RH

$279.20 /

-10.88 (-3.75%)

, NVCR

Novocure

$66.48 /

+1.23 (+1.89%)

, SVFC

SVF Investment Corp. 3

$9.94 /

+ (+0.00%)

, WMT

Walmart

$147.88 /

-0.16 (-0.11%)

, SYM

Symbotic

/

+

, DKNG

DraftKings

$13.13 /

+0.52 (+4.12%)

Institutional investors…

ShowHide Related Items >><<
WOOF Petco
$18.08 /

-0.565 (-3.03%)

WMT Walmart
$147.88 /

-0.16 (-0.11%)

TWLO Twilio
$106.55 /

-4.24 (-3.83%)

TTD Trade Desk
$52.86 /

+0.925 (+1.78%)

TCEHY Tencent
$45.94 /

+1.881 (+4.27%)

SVFC SVF Investment Corp. 3
$9.94 /

+ (+0.00%)

SFT Shift Technologies
$1.17 /

-0.025 (-2.09%)

RNG RingCentral
$67.23 /

-2.03 (-2.93%)

RH RH
$279.20 /

-10.88 (-3.75%)

PDD Pinduoduo
$38.32 /

+0.62 (+1.64%)

NVCR Novocure
$66.48 /

+1.23 (+1.89%)

NTES NetEase
$94.12 /

+1.64 (+1.77%)

NLSN Nielsen
$24.97 /

-0.17 (-0.68%)

NFLX Netflix
$191.97 /

+4.26 (+2.27%)

MPC Marathon Petroleum
$97.02 /

+1.04 (+1.08%)

JD JD.com
$52.10 /

+0.55 (+1.07%)

INM InMed Pharmaceuticals
/

+

DKNG DraftKings
$13.13 /

+0.52 (+4.12%)

DIS Disney
$106.80 /

-0.56 (-0.52%)

CI Cigna
$264.05 /

+4.84 (+1.87%)

BILI Bilibili
$20.93 /

+0.35 (+1.70%)

BIDU Baidu
$117.00 /

+0.11 (+0.09%)

BAND Bandwidth
$20.15 /

-0.94 (-4.46%)

BABA Alibaba
$87.73 /

-0.185 (-0.21%)

NFLX Netflix
$191.97 /

+4.26 (+2.27%)

05/16/22 Wedbush
Wedbush sees Netflix positioned to exceed Q2 guidance, upgrades to Outperform
05/16/22 Wedbush
Netflix upgraded to Outperform from Neutral at Wedbush
05/16/22 Stifel
Trade Desk upgraded to Buy from Hold at Stifel
05/13/22 JPMorgan
JPMorgan lays out three major investor concerns on Netflix
BABA Alibaba
$87.73 /

-0.185 (-0.21%)

05/16/22 JPMorgan
Alibaba upgraded to Overweight from Underweight at JPMorgan
05/02/22 Mizuho
Alibaba price target lowered to $160 from $180 at Mizuho
04/11/22 UBS
Alibaba price target lowered to $140 from $150 at UBS
04/10/22 Goldman Sachs
Alibaba assumed with a Buy at Goldman Sachs
PDD Pinduoduo
$38.32 /

+0.62 (+1.64%)

05/16/22 JPMorgan
Pinduoduo upgraded to Overweight from Underweight at JPMorgan
04/29/22 86 Research
Pinduoduo upgraded to Buy from Hold at 86 Research
04/10/22 Goldman Sachs
Pinduoduo assumed with a Buy at Goldman Sachs
03/23/22 UBS
UBS upgrades Pinduoduo to Buy on gross margin expansion offsetting slower growth
TCEHY Tencent
$45.94 /

+1.881 (+4.27%)

05/16/22 JPMorgan
Tencent upgraded to Overweight from Underweight at JPMorgan
05/02/22 Mizuho
Tencent price target lowered to HK$400 from HK$450 at Mizuho
04/10/22 Goldman Sachs
Tencent assumed with a Conviction Buy at Goldman Sachs
03/25/22 Barclays
Tencent price target lowered to $55 from $76 at Barclays
JD JD.com
$52.10 /

+0.55 (+1.07%)

05/16/22 JPMorgan
JD.com upgraded to Neutral from Underweight at JPMorgan
05/02/22 Mizuho
JD.com price target lowered to $90 from $100 at Mizuho
04/13/22 CLSA
JD.com price target lowered to $100 from $108 at CLSA
03/16/22 US Tiger
China Internet sector upgraded to Outperform from Neutral at US Tiger
BIDU Baidu
$117.00 /

+0.11 (+0.09%)

05/16/22 JPMorgan
Baidu upgraded to Neutral from Underweight at JPMorgan
05/02/22 Mizuho
Baidu price target lowered to $285 from $300 at Mizuho
04/10/22 Goldman Sachs
Baidu assumed with a Buy at Goldman Sachs
04/08/22 HSBC
Baidu price target lowered to $180 from $195 at HSBC
BILI Bilibili
$20.93 /

+0.35 (+1.70%)

05/16/22 JPMorgan
Bilibili upgraded to Neutral from Underweight at JPMorgan
05/03/22 Barclays
Bilibili price target lowered to $24 from $32 at Barclays
04/10/22 Goldman Sachs
Bilibili assumed with a Neutral at Goldman Sachs
03/24/22 KGI Securities
Bilibili downgraded to Neutral from Outperform at KGI Securities
NTES NetEase
$94.12 /

+1.64 (+1.77%)

05/16/22 JPMorgan
NetEase upgraded to Overweight from Underweight at JPMorgan
04/10/22 Goldman Sachs
NetEase assumed with a Buy at Goldman Sachs
03/14/22 JPMorgan
NetEase double downgraded to Underweight at JPMorgan amid sector-wide selloff
CI Cigna
$264.05 /

+4.84 (+1.87%)

05/16/22 JPMorgan
Cigna upgraded to Overweight from Neutral at JPMorgan
05/10/22 Raymond James
Cigna price target raised to $300 from $275 at Raymond James
05/09/22 Oppenheimer
Cigna price target raised to $310 from $300 at Oppenheimer
05/09/22 Cowen
Cigna upgraded to Outperform at Cowen following underperformance
TTD Trade Desk
$52.86 /

+0.925 (+1.78%)

05/12/22 DA Davidson
Trade Desk price target lowered to $65 from $105 at DA Davidson
05/11/22 Wells Fargo
Trade Desk price target lowered to $100 from $120 at Wells Fargo
05/11/22 Susquehanna
Trade Desk price target lowered to $95 from $125 at Susquehanna
TWLO Twilio
$106.55 /

-4.24 (-3.83%)

05/16/22 Baird
Baird downgrades three cloud stocks on focus shift to cash flows
05/16/22 Baird
Twilio downgraded to Neutral from Outperform at Baird
05/09/22 Mizuho
Twilio price target lowered to $200 from $300 at Mizuho
05/05/22 BTIG
Twilio price target lowered to $230 from $270 at BTIG
DIS Disney
$106.80 /

-0.56 (-0.52%)

05/13/22 Barclays
Disney price target lowered to $130 from $168 at Barclays
05/12/22 RBC Capital
Disney price target lowered to $176 from $210 at RBC Capital
05/12/22 BMO Capital
Disney price target lowered to $135 from $140 at BMO Capital
RNG RingCentral
$67.23 /

-2.03 (-2.93%)

05/16/22 Baird
RingCentral downgraded to Neutral from Outperform at Baird
05/10/22 Northland
RingCentral price target lowered to $175 from $275 at Northland
05/10/22 Craig-Hallum
RingCentral price target lowered to $175 from $270 at Craig-Hallum
BAND Bandwidth
$20.15 /

-0.94 (-4.46%)

05/16/22 Baird
Bandwidth downgraded to Neutral from Outperform at Baird
05/06/22 Needham
Bandwidth downgraded to Hold from Buy at Needham
05/05/22 Canaccord
Bandwidth price target lowered to $71 from $86 at Canaccord
SFT Shift Technologies
$1.17 /

-0.025 (-2.09%)

05/16/22 Benchmark
Shift Technologies downgraded to Hold at Benchmark on higher financing cost
05/16/22 Benchmark
Shift Technologies downgraded to Hold from Buy at Benchmark
05/11/22 Cantor Fitzgerald
Shift Technologies price target lowered to $4 from $8 at Cantor Fitzgerald
05/04/22 BTIG
Shift Technologies downgraded to Neutral from Buy at BTIG
NLSN Nielsen
$24.97 /

-0.17 (-0.68%)

05/16/22 BMO Capital
Nielsen downgraded to Market Perform from Outperform at BMO Capital
03/30/22 Jefferies
Nielsen downgraded to Hold from Buy at Jefferies
03/29/22 Morgan Stanley
Morgan Stanley raises Nielsen to Equal Weight, says 'may be better off private'
03/29/22 Morgan Stanley
Nielsen upgraded to Equal Weight from Underweight at Morgan Stanley
MPC Marathon Petroleum
$97.02 /

+1.04 (+1.08%)

05/16/22 Goldman Sachs
Marathon Petroleum downgraded to Neutral from Buy at Goldman Sachs
05/04/22 Credit Suisse
Marathon Petroleum price target raised to $110 from $100 at Credit Suisse
04/26/22 Citi
Marathon Petroleum price target raised to $108 from $85 at Citi
04/18/22 Morgan Stanley
Marathon Petroleum price target raised to $115 from $90 at Morgan Stanley
INM InMed Pharmaceuticals
/

+

05/16/22 Roth Capital
InMed Pharmaceuticals downgraded to Neutral from Buy at Roth Capital
11/29/21 H.C. Wainwright
InMed Pharmaceuticals initiated with a Buy at H.C. Wainwright
WOOF Petco
$18.08 /

-0.565 (-3.03%)

05/16/22 Morgan Stanley
Petco initiated with an Equal Weight at Morgan Stanley
05/13/22 Citi
Petco price target lowered to $26 from $28 at Citi
04/14/22 Citi
Petco price target raised to $28 from $26 at Citi
03/29/22 Wedbush
Petco added to Best Ideas List at Wedbush
RH RH
$279.20 /

-10.88 (-3.75%)

05/16/22 Morgan Stanley
RH initiated with an Equal Weight at Morgan Stanley
05/06/22 Gordon Haskett
RH downgraded to Hold from Accumulate at Gordon Haskett
04/19/22 Guggenheim
RH 'capital structure cleansing' amplifies long-term bull case, says Guggenheim
04/01/22 Loop Capital
RH price target lowered to $700 from $800 at Loop Capital
NVCR Novocure
$66.48 /

+1.23 (+1.89%)

05/16/22 H.C. Wainwright
Novocure initiated with a Buy at H.C. Wainwright
05/13/22 Piper Sandler
Novocure price target lowered to $100 from $125 at Piper Sandler
02/07/22 Loop Capital
Loop starts Tumor Treating Fields 'pioneer' Novocure with a Buy
02/07/22 Loop Capital
Novocure initiated with a Buy at Loop Capital
SVFC SVF Investment Corp. 3
$9.94 /

+ (+0.00%)

05/16/22 Northland
SVF Investment Corp. 3 initiated with an Outperform at Northland
WMT Walmart
$147.88 /

-0.16 (-0.11%)

05/16/22 Deutsche Bank
Walmart price target lowered to $181 from $184 at Deutsche Bank
04/20/22 B. Riley
Plug Power agreement with Walmart 'solid validation,' says B. Riley
04/13/22 Morgan Stanley
PayPal CFO exit 'may be perceived as negative signaling,' says Morgan Stanley
SYM Symbotic
/

+

DKNG DraftKings
$13.13 /

+0.52 (+4.12%)

05/16/22 Jefferies
DraftKings reinstated with a Buy at Jefferies
05/09/22 Northland
DraftKings price target lowered to $25 from $40 at Northland
05/09/22 Craig-Hallum
DraftKings price target lowered to $30 from $40 at Craig-Hallum
05/09/22 Oppenheimer
DraftKings price target lowered to $24 from $32 at Oppenheimer
WOOF Petco
$18.08 /

-0.565 (-3.03%)

WMT Walmart
$147.88 /

-0.16 (-0.11%)

TWLO Twilio
$106.55 /

-4.24 (-3.83%)

TTD Trade Desk
$52.86 /

+0.925 (+1.78%)

SFT Shift Technologies
$1.17 /

-0.025 (-2.09%)

RNG RingCentral
$67.23 /

-2.03 (-2.93%)

RH RH
$279.20 /

-10.88 (-3.75%)

PDD Pinduoduo
$38.32 /

+0.62 (+1.64%)

NVCR Novocure
$66.48 /

+1.23 (+1.89%)

NLSN Nielsen
$24.97 /

-0.17 (-0.68%)

NFLX Netflix
$191.97 /

+4.26 (+2.27%)

MPC Marathon Petroleum
$97.02 /

+1.04 (+1.08%)

JD JD.com
$52.10 /

+0.55 (+1.07%)

INM InMed Pharmaceuticals
/

+

DKNG DraftKings
$13.13 /

+0.52 (+4.12%)

DIS Disney
$106.80 /

-0.56 (-0.52%)

CI Cigna
$264.05 /

+4.84 (+1.87%)

BILI Bilibili
$20.93 /

+0.35 (+1.70%)

BIDU Baidu
$117.00 /

+0.11 (+0.09%)

BAND Bandwidth
$20.15 /

-0.94 (-4.46%)

BABA Alibaba
$87.73 /

-0.185 (-0.21%)

  • 27
    May
WMT Walmart
$147.88 /

-0.16 (-0.11%)

TCEHY Tencent
$45.94 /

+1.881 (+4.27%)

RH RH
$279.20 /

-10.88 (-3.75%)

PDD Pinduoduo
$38.32 /

+0.62 (+1.64%)

NTES NetEase
$94.12 /

+1.64 (+1.77%)

NLSN Nielsen
$24.97 /

-0.17 (-0.68%)

NFLX Netflix
$191.97 /

+4.26 (+2.27%)

MPC Marathon Petroleum
$97.02 /

+1.04 (+1.08%)

DKNG DraftKings
$13.13 /

+0.52 (+4.12%)

DIS Disney
$106.80 /

-0.56 (-0.52%)

CI Cigna
$264.05 /

+4.84 (+1.87%)

BILI Bilibili
$20.93 /

+0.35 (+1.70%)

BIDU Baidu
$117.00 /

+0.11 (+0.09%)

BABA Alibaba
$87.73 /

-0.185 (-0.21%)

WOOF Petco
$18.08 /

-0.565 (-3.03%)

WMT Walmart
$147.88 /

-0.16 (-0.11%)

TWLO Twilio
$106.55 /

-4.24 (-3.83%)

TTD Trade Desk
$52.86 /

+0.925 (+1.78%)

TCEHY Tencent
$45.94 /

+1.881 (+4.27%)

SFT Shift Technologies
$1.17 /

-0.025 (-2.09%)

RNG RingCentral
$67.23 /

-2.03 (-2.93%)

RH RH
$279.20 /

-10.88 (-3.75%)

NLSN Nielsen
$24.97 /

-0.17 (-0.68%)

NFLX Netflix
$191.97 /

+4.26 (+2.27%)

MPC Marathon Petroleum
$97.02 /

+1.04 (+1.08%)

INM InMed Pharmaceuticals
/

+

DKNG DraftKings
$13.13 /

+0.52 (+4.12%)

DIS Disney
$106.80 /

-0.56 (-0.52%)

CI Cigna
$264.05 /

+4.84 (+1.87%)

BILI Bilibili
$20.93 /

+0.35 (+1.70%)

BIDU Baidu
$117.00 /

+0.11 (+0.09%)

BAND Bandwidth
$20.15 /

-0.94 (-4.46%)

BABA Alibaba
$87.73 /

-0.185 (-0.21%)

WOOF Petco
$18.08 /

-0.565 (-3.03%)

WMT Walmart
$147.88 /

-0.16 (-0.11%)

TWLO Twilio
$106.55 /

-4.24 (-3.83%)

TTD Trade Desk
$52.86 /

+0.925 (+1.78%)

SFT Shift Technologies
$1.17 /

-0.025 (-2.09%)

RNG RingCentral
$67.23 /

-2.03 (-2.93%)

RH RH
$279.20 /

-10.88 (-3.75%)

PDD Pinduoduo
$38.32 /

+0.62 (+1.64%)

NLSN Nielsen
$24.97 /

-0.17 (-0.68%)

NFLX Netflix
$191.97 /

+4.26 (+2.27%)

MPC Marathon Petroleum
$97.02 /

+1.04 (+1.08%)

JD JD.com
$52.10 /

+0.55 (+1.07%)

DKNG DraftKings
$13.13 /

+0.52 (+4.12%)

DIS Disney
$106.80 /

-0.56 (-0.52%)

CI Cigna
$264.05 /

+4.84 (+1.87%)

BILI Bilibili
$20.93 /

+0.35 (+1.70%)

BIDU Baidu
$117.00 /

+0.11 (+0.09%)

BABA Alibaba
$87.73 /

-0.185 (-0.21%)

Hot Stocks
Verano Holdings launches mobile applications, rewards programs » 07:45
05/16/22
05/16
07:45
05/16/22
07:45
VRNOF

Verano Holdings

$7.69 /

+0.34 (+4.63%)

Verano Holdings announced…

Verano Holdings announced the launch of mobile applications for the Company's flagship Zen Leaf and MUV dispensaries, unlocking an additional digital channel for shoppers to order cannabis products and access exclusive rewards across a total of 71 dispensaries in seven states. "Since Verano's inception, we've taken pride in fostering an exceptional environment for our guests by ensuring that customer care, convenience, accessibility, and first-class service are perpetual elements of our shoppers' experience," said George Archos, Verano Founder and Chief Executive Officer. "Offering our Zen Leaf and MUV mobile applications is a natural extension of our customer-first mindset, and we're thrilled to deliver this additional channel for our valued guests to access our suite of premium products and exclusive rewards from their preferred devices."

ShowHide Related Items >><<
VRNOF Verano Holdings
$7.69 /

+0.34 (+4.63%)

VRNOF Verano Holdings
$7.69 /

+0.34 (+4.63%)

04/28/22 Canaccord
Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord
02/11/22 Alliance Global Partners
Verano Holdings initiated with a Buy at Alliance Global Partners
02/09/22 Needham
Verano Holdings initiated with a Buy at Needham
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
VRNOF Verano Holdings
$7.69 /

+0.34 (+4.63%)

VRNOF Verano Holdings
$7.69 /

+0.34 (+4.63%)

Downgrade
InMed Pharmaceuticals downgraded to Neutral from Buy at Roth Capital » 07:09
05/16/22
05/16
07:09
05/16/22
07:09
INM

InMed Pharmaceuticals

/

+

Roth Capital analyst…

Roth Capital analyst Scott Henry downgraded InMed Pharmaceuticals to Neutral from Buy with a price target of $0.80, down from $6. While "intrigued" by the commercial business, he has concerns about the viability of the R&D unit in the current market environment and he has adopted conservative valuation metrics given concerns with the ability to finance and the potential for a recapitalization, Henry tells investors.

ShowHide Related Items >><<
INM InMed Pharmaceuticals
/

+

INM InMed Pharmaceuticals
/

+

11/29/21 H.C. Wainwright
InMed Pharmaceuticals initiated with a Buy at H.C. Wainwright
INM InMed Pharmaceuticals
/

+

INM InMed Pharmaceuticals
/

+

Earnings
InMed Pharmaceuticals reports Q3 EPS (25c) vs (41c) last year » 07:33
05/13/22
05/13
07:33
05/13/22
07:33
INM

InMed Pharmaceuticals

/

+

Reports Q3 revenue…

Reports Q3 revenue $309,585 vs $0 last year. "The third quarter of fiscal 2022 saw noticeable advancements across all of our programs, including commencing sales of the rare cannabinoids CBDV and CBT as raw ingredients for the health and wellness industry," says Eric A. Adams, InMed President & CEO. "For the remainder of fiscal 2022, we will remain focused on driving our commercial operations by expanding our product portfolio, increasing sales of our existing and new rare cannabinoids, exploring new distribution channels and optimizing our product development and supply chain strategy. We continue to grow revenues and have established a solid platform upon which to build as we commercialize additional high value products. We continue to focus on enhancing our sales and marketing efforts to support increasing demand."

ShowHide Related Items >><<
INM InMed Pharmaceuticals
/

+

INM InMed Pharmaceuticals
/

+

11/29/21 H.C. Wainwright
InMed Pharmaceuticals initiated with a Buy at H.C. Wainwright
INM InMed Pharmaceuticals
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.